- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2021 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Latest Conference Articles
Jessica Walsh, MD: Patient Perspectives of Biologic Treatments for Axial Spondyloarthritis
June 9th 2021
EULAR European Congress of Rheumatology
Rheumatology Network spoke with Jessica Walsh, MD, to discuss her study, “Patient perspectives of biologic treatments for axial spondyloarthritis: satisfaction, wear-off between doses, and use of supplemental medications."
Alyssa Johnsen, MD, PhD: Guselkumab Improves Joint Symptoms and Skin Clearance in Psoriatic Arthritis
June 8th 2021
EULAR European Congress of Rheumatology
Alyssa Johnsen, MD, PhD, spoke with Rheumatology Network about the efficacy of guselkumab for psoriatic arthritis, the challenges of delivering safe and effective treatments in this patient population, and how guselkumab can help improve physical, social, and work activity for these patients.
Benjamin Nowell, PhD: Mindfulness Program for Patients With Rheumatic Disease
June 8th 2021
EULAR European Congress of Rheumatology
Rheumatology Network sat down for an interview with Benjamin Nowell, PhD, in partnership with CreakyJoints, to discuss the Healthy Mind Healthy You study, which assessed 2 mindfulness programs of varying lengths, designed for people with rheumatic disease, and compared the results.
Pedro Machado, MD, PhD: COVID-19 Vaccine Safety in Patients With Rheumatic and Musculoskeletal Disease
June 7th 2021
EULAR European Congress of Rheumatology
Rheumatology Network sat down with Pedro Machado, MD, PhD, to discuss his EULAR 2021 presentation entitled, “COVID-19 vaccine safety in patients with rheumatic and musculoskeletal disease.”
Roy Fleischmann, MD: Efficacy of Upadacitinib and Adalimumab for Rheumatoid Arthritis
June 4th 2021
EULAR European Congress of Rheumatology
Roy Fleischmann, MD, discusses his presentations for EULAR 2021, which include topics about the side effects of JAK inhibitors, disease activity measures of methotrexate withdrawal among patients with rheumatoid arthritis, and the long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis.
Neil Solomons, MD: Efficacy of Voclosporin for Treatment of Lupus Nephritis
June 3rd 2021
EULAR European Congress of Rheumatology
Neil Solomons, MD, sits down to discuss his latest study, entitled “Aurinia Announces Publication of AURORA 1 Phase 3 Study Results with LUPKYNIS™ (voclosporin) in The Lancet,” which will be presented at EULAR 2021.
.jpeg?w=350&fit=crop&auto=format)
Improved Psoriatic Arthritis Outcomes in Phase 3b Guselkumab Trial
June 3rd 2021
EULAR European Congress of Rheumatology
Data from the COSMOS study showed that 44.4% of patients who received guselkumab versus 19.8% of patients who received placebo achieved a ≥20% improvement at week 24.
John Botson, MD, RPh, CCD: Pegloticase Efficacy and Safety in Patients With Gout
June 2nd 2021
EULAR European Congress of Rheumatology
As a part of our EULAR 2021 coverage, Rheumatology Network sat down with John Botson, MD, RPh, CCD, to discuss why patients with uncontrolled gout are significantly burdened with systemic co-morbid disease, why gout is more prevalent and severe in patients who have received kidney transplants, and why such few studies have been published on the use of pegloticase in organ transplant patients.
Elena Nikiphorou, MBBS/BSc, MD (Res): Self-Management Strategies for Patients With Arthritis
May 26th 2021
EULAR European Congress of Rheumatology
Rheumatology Networked interviewed Elena Nikiphorou, MBBS/BSc, MD (Res), to discuss her recent study that suggests self-management and resources for patients with inflammatory arthritis improve patient experience of care and outcomes by empowering and supporting them.
Rebecca Manno, MD, MHS: ACR SOTA Clinical Symposium
April 19th 2021
American College of Rheumatology's State of the Art Clinical Symposium (ACR-SOTA)
Rheumatology Network sat down with Rebecca Manno, MD, MHS, to discuss the American College of Rheumatology State of the Art (ACR SOTA) Clinical Symposium, which ran from April 9-11.